BAVIS_1170x120_1-20

GA Depot

Mylan to partner with Mapi Pharma on new MS drug

Mylan to partner with Mapi Pharma on new MS drug

HERTFORDSHIRE, England and PITTSBURGH and NESS ZIONA, Israel — Mylan N.V. and Mapi Pharma Ltd. announced that the two companies will team on the development and commercialization of GA Depot, a long-acting Glatiramer Acetate product. Mylan is acquiring global marketing rights to the product. GA Depot is a proposed once-monthly injection for the treatment of